504 related articles for article (PubMed ID: 8197926)
1. Design and analysis of prostate cancer trials.
Sylvester R
Acta Urol Belg; 1994 Apr; 62(1):23-9. PubMed ID: 8197926
[TBL] [Abstract][Full Text] [Related]
2. Statistical considerations for the design and analysis of Phase III clinical trials in prostate cancer.
Halabi S
Urol Oncol; 2008; 26(3):300-7. PubMed ID: 18452825
[TBL] [Abstract][Full Text] [Related]
3. Performance of adaptive sample size adjustment with respect to stopping criteria and time of interim analysis.
Jahn-Eimermacher A; Hommel G
Stat Med; 2007 Mar; 26(7):1450-61. PubMed ID: 16900553
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for randomization and stratification and endpoints for the evaluation of trials.
Sylvester RJ; Suciu S; Yamanaka H
Prog Clin Biol Res; 1988; 269():275-87. PubMed ID: 3293065
[No Abstract] [Full Text] [Related]
5. Randomized phase II designs in cancer clinical trials: current status and future directions.
Lee JJ; Feng L
J Clin Oncol; 2005 Jul; 23(19):4450-7. PubMed ID: 15994154
[TBL] [Abstract][Full Text] [Related]
6. Interim analyses in 2 x 2 crossover trials.
Cook RJ
Biometrics; 1995 Sep; 51(3):932-45. PubMed ID: 7548709
[TBL] [Abstract][Full Text] [Related]
7. Designing for cancer clinical trials: selection of prognostic factors.
Brown BW
Cancer Treat Rep; 1980; 64(2-3):499-502. PubMed ID: 7407790
[TBL] [Abstract][Full Text] [Related]
8. A general statistical principle for changing a design any time during the course of a trial.
Müller HH; Schäfer H
Stat Med; 2004 Aug; 23(16):2497-508. PubMed ID: 15287080
[TBL] [Abstract][Full Text] [Related]
9. Assessment of futility in clinical trials.
Snapinn S; Chen MG; Jiang Q; Koutsoukos T
Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
[TBL] [Abstract][Full Text] [Related]
10. Incorporating intermediate binary responses into interim analyses of clinical trials: a comparison of four methods.
Whitehead A; Sooriyarachchi MR; Whitehead J; Bolland K
Stat Med; 2008 May; 27(10):1646-66. PubMed ID: 17886243
[TBL] [Abstract][Full Text] [Related]
11. General statistical design considerations of randomized clinical trials.
Peduzzi P
Prog Clin Biol Res; 1988; 264():61-70. PubMed ID: 3289035
[TBL] [Abstract][Full Text] [Related]
12. Biostatistics in clinical trials: Part 2. Determining sample sizes for clinical trials.
Ellenberg SS
Oncology (Williston Park); 1989 Aug; 3(8):39-46; discussion 48, 51. PubMed ID: 2519197
[TBL] [Abstract][Full Text] [Related]
13. Randomization as a basis for inference in noninferiority trials.
Wiens BL
Pharm Stat; 2006; 5(4):265-71. PubMed ID: 17128425
[TBL] [Abstract][Full Text] [Related]
14. Stopping clinical trials because of treatment ineffectiveness: a comparison of a futility design with a method of stochastic curtailment.
Whitehead J; Matsushita T
Stat Med; 2003 Mar; 22(5):677-87. PubMed ID: 12587099
[TBL] [Abstract][Full Text] [Related]
15. Size of phase III cancer clinical trials.
Simon R
Cancer Treat Rep; 1985 Oct; 69(10):1087-93. PubMed ID: 4042088
[No Abstract] [Full Text] [Related]
16. Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners.
Geller NL; Pocock SJ
Biometrics; 1987 Mar; 43(1):213-23. PubMed ID: 3567306
[TBL] [Abstract][Full Text] [Related]
17. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis.
Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
Circulation; 2004 Jun; 109(21):e305-7. PubMed ID: 15173053
[No Abstract] [Full Text] [Related]
18. Issues in the meta-analysis of cluster randomized trials.
Donner A; Klar N
Stat Med; 2002 Oct; 21(19):2971-80. PubMed ID: 12325113
[TBL] [Abstract][Full Text] [Related]
19. Design and analytic concepts for periodontal clinical trials.
Imrey PB; Chilton NW
J Periodontol; 1992 Dec; 63(12 Suppl):1124-40. PubMed ID: 1479532
[TBL] [Abstract][Full Text] [Related]
20. Sequential clinical trials in cancer research.
George SL
Cancer Treat Rep; 1980; 64(2-3):393-7. PubMed ID: 7407775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
